Global Regenerative Medicine Market: Size & Forecast with Impact Analysis of COVID-19 (2020-2024)
Scope of the Report
The report titled “Global Regenerative Medicine Market: Size & Forecast with Impact Analysis of COVID-19 (2020-2024)”, provides an in-depth analysis of the global regenerative medicine market with description of market sizing and growth. The analysis includes market by value, by product, by material and by region. Furthermore, the report also provides detailed product analysis, material analysis and regional analysis.
Moreover, the report also assesses the key opportunities in the market and outlines the factors that are and would be driving the growth of the industry. Growth of the overall global regenerative medicine market has also been forecasted for the years 2020-2024, taking into consideration the previous growth patterns, the growth drivers and the current and future trends.
Some of the major players operating in the global regenerative medicine market are Novartis AG, Medtronic Plc, Bristol Myers Squibb (Celgene Corporation) and Smith+Nephew (Osiris Therapeutics, Inc.), whose company profiling has been done in the report. Furthermore, in this segment of the report, business overview, financial overview and business strategies of the respective companies are also provided.
Region Coverage
Regenerative medicines emphasis on regeneration or replacement of tissues, cells or organs of human body to cure the problem caused by disease or injury. The treatment fortify human cell’s to heal up or transplant stem cells into the body to regenerate lost tissues or organs or to recover impaired functionality. There are three types of stem cells that can be used in regenerative medicine: somatic stem cells, embryonic stem cells (ES cells) and induced pluripotent stem cells (iPS cells).
The regenerative medicine also has the capability to treat chronic diseases and conditions, including Alzheimer’s, diabetes, Parkinson’s, heart disease, osteoporosis, renal failure, spinal cord injuries, etc. Regenerative medicines can be bifurcated into different product type i.e., cell therapy, tissue engineering, gene therapy and small molecules and biologics. In addition, on the basis of material regenerative medicine can be segmented into biologically derived material, synthetic material, genetically engineered materials and pharmaceuticals.
The global regenerative medicine market has surged at a progressive rate over the years and the market is further anticipated to augment during the forecasted years 2020 to 2024. The market would propel owing to numerous growth drivers like growth in geriatric population, rising global healthcare expenditure, increasing diabetic population, escalating number of cancer patients, rising prevalence of cardiovascular disease and surging obese population.
Though, the market faces some challenges which are hindering the growth of the market. Some of the major challenges faced by the industry are: legal obligation and high cost of treatment. Whereas, the market growth would be further supported by various market trends like three dimensional bioprinting , artificial intelligence to advance regenerative medicine, etc.
The report titled “Global Regenerative Medicine Market: Size & Forecast with Impact Analysis of COVID-19 (2020-2024)”, provides an in-depth analysis of the global regenerative medicine market with description of market sizing and growth. The analysis includes market by value, by product, by material and by region. Furthermore, the report also provides detailed product analysis, material analysis and regional analysis.
Moreover, the report also assesses the key opportunities in the market and outlines the factors that are and would be driving the growth of the industry. Growth of the overall global regenerative medicine market has also been forecasted for the years 2020-2024, taking into consideration the previous growth patterns, the growth drivers and the current and future trends.
Some of the major players operating in the global regenerative medicine market are Novartis AG, Medtronic Plc, Bristol Myers Squibb (Celgene Corporation) and Smith+Nephew (Osiris Therapeutics, Inc.), whose company profiling has been done in the report. Furthermore, in this segment of the report, business overview, financial overview and business strategies of the respective companies are also provided.
Region Coverage
- North America
- Europe
- Asia Pacific
- ROW
- Novartis AG
- Medtronic Plc
- Bristol Myers Squibb (Celgene Corporation)
- Smith+Nephew (Osiris Therapeutics, Inc.)
Regenerative medicines emphasis on regeneration or replacement of tissues, cells or organs of human body to cure the problem caused by disease or injury. The treatment fortify human cell’s to heal up or transplant stem cells into the body to regenerate lost tissues or organs or to recover impaired functionality. There are three types of stem cells that can be used in regenerative medicine: somatic stem cells, embryonic stem cells (ES cells) and induced pluripotent stem cells (iPS cells).
The regenerative medicine also has the capability to treat chronic diseases and conditions, including Alzheimer’s, diabetes, Parkinson’s, heart disease, osteoporosis, renal failure, spinal cord injuries, etc. Regenerative medicines can be bifurcated into different product type i.e., cell therapy, tissue engineering, gene therapy and small molecules and biologics. In addition, on the basis of material regenerative medicine can be segmented into biologically derived material, synthetic material, genetically engineered materials and pharmaceuticals.
The global regenerative medicine market has surged at a progressive rate over the years and the market is further anticipated to augment during the forecasted years 2020 to 2024. The market would propel owing to numerous growth drivers like growth in geriatric population, rising global healthcare expenditure, increasing diabetic population, escalating number of cancer patients, rising prevalence of cardiovascular disease and surging obese population.
Though, the market faces some challenges which are hindering the growth of the market. Some of the major challenges faced by the industry are: legal obligation and high cost of treatment. Whereas, the market growth would be further supported by various market trends like three dimensional bioprinting , artificial intelligence to advance regenerative medicine, etc.
1. EXECUTIVE SUMMARY
2. INTRODUCTION
2.1 Regenerative Medicine: An Overview
2.2 Regeneration in Humans: An Overview
2.3 Expansion in Peripheral Industries of Regenerative Medicine
2.4 Approval System for Regenerative Medicine Products
2.5 Regenerative Medicine Segmentation
3. GLOBAL MARKET ANALYSIS
3.1 Global Regenerative Medicine Market: An Analysis
3.1.1 Global Regenerative Medicine Market by Value
3.1.2 Global Regenerative Medicine Market by Products (Cell Therapy, Tissue Engineering, Gene Therapy and Small Molecules and Biologics)
3.1.3 Global Regenerative Medicine Market by Material (Biologically Derived Material, Synthetic Material, Genetically Engineered Materials and Pharmaceuticals)
3.1.4 Global Regenerative Medicine Market by Region (North America, Europe, Asia Pacific and ROW)
3.2 Global Regenerative Medicine Market: Product Analysis
3.2.1 Global Cell Therapy Regenerative Medicine Market by Value
3.2.2 Global Tissue Engineering Regenerative Medicine Market by Value
3.2.3 Global Gene Therapy Regenerative Medicine Market by Value
3.2.4 Global Small Molecules and Biologics Regenerative Medicine Market by Value
3.3 Global Regenerative Medicine Market: Material Analysis
3.3.1 Global Biologically Derived Material Market by Value
3.3.2 Global Synthetic Material Market by Value
3.3.3 Global Genetically Engineered Materials Market by Value
3.3.4 Global Regenerative Medicine Pharmaceuticals Market by Value
4. REGIONAL MARKET ANALYSIS
4.1 North America Regenerative Medicine Market: An Analysis
4.1.1 North America Regenerative Medicine Market by Value
4.2 Europe Regenerative Medicine Market: An Analysis
4.2.1 Europe Regenerative Medicine Market by Value
4.3 Asia Pacific Regenerative Medicine Market: An Analysis
4.3.1 Asia Pacific Regenerative Medicine Market by Value
4.4 ROW Regenerative Medicine Market: An Analysis
4.4.1 ROW Regenerative Medicine Market by Value
5. COVID-19
5.1 Impact of Covid-19
5.2 Response of Industry to Covid-19
5.3 Variation in Organic Traffic
5.4 Regional Impact of COVID-19
6. MARKET DYNAMICS
6.1 Growth Drivers
6.1.1 Growth in Geriatric Population
6.1.2 Rising Global Healthcare Expenditure
6.1.3 Increasing Diabetic Population
6.1.4 Escalating Number of Cancer Patients
6.1.5 Rising Prevalence of Cardiovascular Disease
6.1.6 Surging Obese Population
6.2 Challenges
6.2.1 Legal Obligation
6.2.2 High Cost of Treatment
6.3 Market Trends
6.3.1 3D Bio-Printing
6.3.2 Artificial Intelligence to Advance Regenerative Medicine
7. COMPETITIVE LANDSCAPE
7.1 Global Regenerative Medicine Market Players: A Financial Comparison
7.2 Global Regenerative Medicine Market Players’ by Research & Development Expenditure
8. COMPANY PROFILES
8.1 Bristol Myers Squibb (Celgene Corporation)
8.1.1 Business Overview
8.1.2 Financial Overview
8.1.3 Business Strategy
8.2 Medtronic Plc
8.2.1 Business Overview
8.2.2 Financial Overview
8.2.3 Business Strategy
8.3 Smith+Nephew (Osiris Therapeutics, Inc.)
8.3.1 Business Overview
8.3.2 Financial Overview
8.3.3 Business Strategy
8.4 Novartis AG
8.4.1 Business Overview
8.4.2 Financial Overview
8.4.3 Business Strategy
2. INTRODUCTION
2.1 Regenerative Medicine: An Overview
2.2 Regeneration in Humans: An Overview
2.3 Expansion in Peripheral Industries of Regenerative Medicine
2.4 Approval System for Regenerative Medicine Products
2.5 Regenerative Medicine Segmentation
3. GLOBAL MARKET ANALYSIS
3.1 Global Regenerative Medicine Market: An Analysis
3.1.1 Global Regenerative Medicine Market by Value
3.1.2 Global Regenerative Medicine Market by Products (Cell Therapy, Tissue Engineering, Gene Therapy and Small Molecules and Biologics)
3.1.3 Global Regenerative Medicine Market by Material (Biologically Derived Material, Synthetic Material, Genetically Engineered Materials and Pharmaceuticals)
3.1.4 Global Regenerative Medicine Market by Region (North America, Europe, Asia Pacific and ROW)
3.2 Global Regenerative Medicine Market: Product Analysis
3.2.1 Global Cell Therapy Regenerative Medicine Market by Value
3.2.2 Global Tissue Engineering Regenerative Medicine Market by Value
3.2.3 Global Gene Therapy Regenerative Medicine Market by Value
3.2.4 Global Small Molecules and Biologics Regenerative Medicine Market by Value
3.3 Global Regenerative Medicine Market: Material Analysis
3.3.1 Global Biologically Derived Material Market by Value
3.3.2 Global Synthetic Material Market by Value
3.3.3 Global Genetically Engineered Materials Market by Value
3.3.4 Global Regenerative Medicine Pharmaceuticals Market by Value
4. REGIONAL MARKET ANALYSIS
4.1 North America Regenerative Medicine Market: An Analysis
4.1.1 North America Regenerative Medicine Market by Value
4.2 Europe Regenerative Medicine Market: An Analysis
4.2.1 Europe Regenerative Medicine Market by Value
4.3 Asia Pacific Regenerative Medicine Market: An Analysis
4.3.1 Asia Pacific Regenerative Medicine Market by Value
4.4 ROW Regenerative Medicine Market: An Analysis
4.4.1 ROW Regenerative Medicine Market by Value
5. COVID-19
5.1 Impact of Covid-19
5.2 Response of Industry to Covid-19
5.3 Variation in Organic Traffic
5.4 Regional Impact of COVID-19
6. MARKET DYNAMICS
6.1 Growth Drivers
6.1.1 Growth in Geriatric Population
6.1.2 Rising Global Healthcare Expenditure
6.1.3 Increasing Diabetic Population
6.1.4 Escalating Number of Cancer Patients
6.1.5 Rising Prevalence of Cardiovascular Disease
6.1.6 Surging Obese Population
6.2 Challenges
6.2.1 Legal Obligation
6.2.2 High Cost of Treatment
6.3 Market Trends
6.3.1 3D Bio-Printing
6.3.2 Artificial Intelligence to Advance Regenerative Medicine
7. COMPETITIVE LANDSCAPE
7.1 Global Regenerative Medicine Market Players: A Financial Comparison
7.2 Global Regenerative Medicine Market Players’ by Research & Development Expenditure
8. COMPANY PROFILES
8.1 Bristol Myers Squibb (Celgene Corporation)
8.1.1 Business Overview
8.1.2 Financial Overview
8.1.3 Business Strategy
8.2 Medtronic Plc
8.2.1 Business Overview
8.2.2 Financial Overview
8.2.3 Business Strategy
8.3 Smith+Nephew (Osiris Therapeutics, Inc.)
8.3.1 Business Overview
8.3.2 Financial Overview
8.3.3 Business Strategy
8.4 Novartis AG
8.4.1 Business Overview
8.4.2 Financial Overview
8.4.3 Business Strategy
LIST OF FIGURES
Figure 1: Type of Stem Cells Used for Regenerative Medicine
Figure 2: Levels of Regeneration in Humans
Figure 3: Expansion in Peripheral Industries of Regenerative Medicine
Figure 4: Approval System for Earlier Application of Regenerative Medicine Products
Figure 5: Regenerative Medicine Segmentation
Figure 6: Global Regenerative Medicine Market by Value; 2015-2019 (US$ Billion)
Figure 7: Global Regenerative Medicine Market by Value; 2020-2024 (US$ Billion)
Figure 8: Global Regenerative Medicine Market by Products; 2019 (Percentage, %)
Figure 9: Global Regenerative Medicine Market by Material; 2019 (Percentage, %)
Figure 10: Global Regenerative Medicine Market by Region; 2019 (Percentage, %)
Figure 11: Global Cell Therapy Regenerative Medicine Market by Value; 2015-2019 (US$ Billion)
Figure 12: Global Cell Therapy Regenerative Medicine Market by Value; 2020-2024 (US$ Billion)
Figure 13: Global Tissue Engineering Regenerative Medicine Market by Value; 2015-2019 (US$ Billion)
Figure 14: Global Tissue Engineering Regenerative Medicine Market by Value; 2020-2024 (US$ Billion)
Figure 15: Global Gene Therapy Regenerative Medicine Market by Value; 2015-2019 (US$ Billion)
Figure 16: Global Gene Therapy Regenerative Medicine Market by Value; 2020-2024 (US$ Billion)
Figure 17: Global Small Molecules and Biologics Regenerative Medicine Market by Value; 2015-2019 (US$ Million)
Figure 18: Global Small Molecules and Biologics Regenerative Medicine Market by Value; 2020-2024 (US$ Billion)
Figure 19: Global Biologically Derived Material Market by Value; 2015-2019 (US$ Billion)
Figure 20: Global Biologically Derived Material Market by Value; 2020-2024 (US$ Billion)
Figure 21: Global Synthetic Material Market by Value; 2015-2019 (US$ Billion)
Figure 22: Global Synthetic Material Market by Value; 2020-2024 (US$ Billion)
Figure 23: Global Genetically Engineered Materials Market by Value; 2015-2019 (US$ Billion)
Figure 24: Global Genetically Engineered Materials Market by Value; 2020-2024 (US$ Billion)
Figure 25: Global Regenerative Medicine Pharmaceuticals Market by Value; 2015-2019 (US$ Billion)
Figure 26: Global Regenerative Medicine Pharmaceuticals Market by Value; 2020-2024 (US$ Billion)
Figure 27: North America Regenerative Medicine Market by Value; 2015-2019 (US$ Billion)
Figure 28: North America Regenerative Medicine Market by Value; 2020-2024 (US$ Billion)
Figure 29: Europe Regenerative Medicine Market by Value; 2015-2019 (US$ Billion)
Figure 30: Europe Regenerative Medicine Market by Value; 2020-2024 (US$ Billion)
Figure 31: Asia Pacific Regenerative Medicine Market by Value; 2015-2019 (US$ Billion)
Figure 32: Asia Pacific Regenerative Medicine Market by Value; 2020-2024 (US$ Billion)
Figure 33: ROW Regenerative Medicine Market by Value; 2015-2019 (US$ Million)
Figure 34: ROW Regenerative Medicine Market by Value; 2020-2024 (US$ Billion)
Figure 35: Variation in Organic Traffic due to COVID-19 (2020), (Percentage, %)
Figure 36: Global Population Proportion above 65 Years of Age; 2019-2030 (Million)
Figure 37: Global Healthcare Expenditure; 2017-2022 (US$ Trillion)
Figure 38: Global Diabetic Population; 2019-2045 (Million)
Figure 39: Global Number of Cancer Patients, 2015-2035 (Million)
Figure 40: Global Cardiovascular Disease Growth Rate; 2016-2025 (Percentage, %)
Figure 41: Global Prevalence of Obesity; 2008-2025 (Billion)
Figure 42: Global Regenerative Medicine Market Player by Research & Development Expenditure; 2017-2019 (US$ Billion)
Figure 43: Bristol Myers Squibb Revenue; 2015-2019 (US$ Billion)
Figure 44: Bristol Myers Squibb Revenue by Product; 2019 (Percentage, %)
Figure 45: Bristol Myers Squibb Revenue by Region; 2019 (Percentage, %)
Figure 46: Medtronic Plc Net Sales; 2015-2019 (US$ Billion)
Figure 47: Medtronic Plc Net Sales by Segments; 2019 (Percentage, %)
Figure 48: Medtronic Plc Net Sales by Region; 2019 (Percentage, %)
Figure 49: Smith+Nephew Revenue; 2015-2019 (US$ Billion)
Figure 50: Smith+Nephew Revenue by Segment; 2019 (Percentage, %)
Figure 51: Smith+Nephew Revenue by Region; 2019 (Percentage, %)
Figure 52: Novartis AG Net Sales; 2015-2019 (US$ Billion)
Figure 53: Novartis AG Net Sales by Segment; 2019 (Percentage, %)
Figure 54: Novartis AG Net Sales by Region; 2019 (Percentage, %)
Table 1: Global Regenerative Medicine Market Players: A Financial Comparison; 2019
Figure 1: Type of Stem Cells Used for Regenerative Medicine
Figure 2: Levels of Regeneration in Humans
Figure 3: Expansion in Peripheral Industries of Regenerative Medicine
Figure 4: Approval System for Earlier Application of Regenerative Medicine Products
Figure 5: Regenerative Medicine Segmentation
Figure 6: Global Regenerative Medicine Market by Value; 2015-2019 (US$ Billion)
Figure 7: Global Regenerative Medicine Market by Value; 2020-2024 (US$ Billion)
Figure 8: Global Regenerative Medicine Market by Products; 2019 (Percentage, %)
Figure 9: Global Regenerative Medicine Market by Material; 2019 (Percentage, %)
Figure 10: Global Regenerative Medicine Market by Region; 2019 (Percentage, %)
Figure 11: Global Cell Therapy Regenerative Medicine Market by Value; 2015-2019 (US$ Billion)
Figure 12: Global Cell Therapy Regenerative Medicine Market by Value; 2020-2024 (US$ Billion)
Figure 13: Global Tissue Engineering Regenerative Medicine Market by Value; 2015-2019 (US$ Billion)
Figure 14: Global Tissue Engineering Regenerative Medicine Market by Value; 2020-2024 (US$ Billion)
Figure 15: Global Gene Therapy Regenerative Medicine Market by Value; 2015-2019 (US$ Billion)
Figure 16: Global Gene Therapy Regenerative Medicine Market by Value; 2020-2024 (US$ Billion)
Figure 17: Global Small Molecules and Biologics Regenerative Medicine Market by Value; 2015-2019 (US$ Million)
Figure 18: Global Small Molecules and Biologics Regenerative Medicine Market by Value; 2020-2024 (US$ Billion)
Figure 19: Global Biologically Derived Material Market by Value; 2015-2019 (US$ Billion)
Figure 20: Global Biologically Derived Material Market by Value; 2020-2024 (US$ Billion)
Figure 21: Global Synthetic Material Market by Value; 2015-2019 (US$ Billion)
Figure 22: Global Synthetic Material Market by Value; 2020-2024 (US$ Billion)
Figure 23: Global Genetically Engineered Materials Market by Value; 2015-2019 (US$ Billion)
Figure 24: Global Genetically Engineered Materials Market by Value; 2020-2024 (US$ Billion)
Figure 25: Global Regenerative Medicine Pharmaceuticals Market by Value; 2015-2019 (US$ Billion)
Figure 26: Global Regenerative Medicine Pharmaceuticals Market by Value; 2020-2024 (US$ Billion)
Figure 27: North America Regenerative Medicine Market by Value; 2015-2019 (US$ Billion)
Figure 28: North America Regenerative Medicine Market by Value; 2020-2024 (US$ Billion)
Figure 29: Europe Regenerative Medicine Market by Value; 2015-2019 (US$ Billion)
Figure 30: Europe Regenerative Medicine Market by Value; 2020-2024 (US$ Billion)
Figure 31: Asia Pacific Regenerative Medicine Market by Value; 2015-2019 (US$ Billion)
Figure 32: Asia Pacific Regenerative Medicine Market by Value; 2020-2024 (US$ Billion)
Figure 33: ROW Regenerative Medicine Market by Value; 2015-2019 (US$ Million)
Figure 34: ROW Regenerative Medicine Market by Value; 2020-2024 (US$ Billion)
Figure 35: Variation in Organic Traffic due to COVID-19 (2020), (Percentage, %)
Figure 36: Global Population Proportion above 65 Years of Age; 2019-2030 (Million)
Figure 37: Global Healthcare Expenditure; 2017-2022 (US$ Trillion)
Figure 38: Global Diabetic Population; 2019-2045 (Million)
Figure 39: Global Number of Cancer Patients, 2015-2035 (Million)
Figure 40: Global Cardiovascular Disease Growth Rate; 2016-2025 (Percentage, %)
Figure 41: Global Prevalence of Obesity; 2008-2025 (Billion)
Figure 42: Global Regenerative Medicine Market Player by Research & Development Expenditure; 2017-2019 (US$ Billion)
Figure 43: Bristol Myers Squibb Revenue; 2015-2019 (US$ Billion)
Figure 44: Bristol Myers Squibb Revenue by Product; 2019 (Percentage, %)
Figure 45: Bristol Myers Squibb Revenue by Region; 2019 (Percentage, %)
Figure 46: Medtronic Plc Net Sales; 2015-2019 (US$ Billion)
Figure 47: Medtronic Plc Net Sales by Segments; 2019 (Percentage, %)
Figure 48: Medtronic Plc Net Sales by Region; 2019 (Percentage, %)
Figure 49: Smith+Nephew Revenue; 2015-2019 (US$ Billion)
Figure 50: Smith+Nephew Revenue by Segment; 2019 (Percentage, %)
Figure 51: Smith+Nephew Revenue by Region; 2019 (Percentage, %)
Figure 52: Novartis AG Net Sales; 2015-2019 (US$ Billion)
Figure 53: Novartis AG Net Sales by Segment; 2019 (Percentage, %)
Figure 54: Novartis AG Net Sales by Region; 2019 (Percentage, %)
Table 1: Global Regenerative Medicine Market Players: A Financial Comparison; 2019
